ESMC
Escalon Medical Corp
$0.19
+0.00 (+0.00%)
At close · Jul 8
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company’s ability to continue as a going concern for the twelve months following issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed May 15, 2026
Market Cap
$1.41M
Shares
7,415,329
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.19
Open$0.19
Day$0.19–0.19
52W$0.10–0.42
Avg vol 30d7K
Short int84K · 1.1% float · 4.2d
Short vol3%
DataJan 2020–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+4%
above
Price vs 50-day avg
−2%
below
RSI (14)
49
neutral
MACD trend
Positive
52-week position
28%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
+19%
trailing
YTD return
+12%
this year
Relative strength
+11%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
1.13% of float · ▬ 0.0% MoM · 4.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
57
elevated · 0–100
Fundamentals
Revenue growth
−2%
Y/Y
EPS growth
+100%
Y/Y
Free cash flow
$376.8K
Valuation
P/E 1.7
below peers
Balance sheet
$545.8K
net cash
Quant / Vol
risk profile
Volatility
154%
annualized · 1-yr
Max drawdown
−69%
past year
ATR
3.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+4%
Bullish
Price vs 50-day avg
−2%
Neutral
RSI (14)
49
Neutral
MACD trend
Positive
Bullish
52-week position
28%
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
1.13% of float · ▬ 0.0% MoM · 4.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 28%
52-wk high $0
vs 200-day avg +4%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ESMC
this stock
Escalon Medical Corp
|
$1.41M | +11.8% | -2.4% | 1.7 | 1.1% |
|
ABT
Abbott Laboratories
|
$165.79B | -23.6% | +5.7% | 26.7 | 1.3% |
|
SYK
Stryker Corp
|
$125.30B | -6.8% | +11.2% | 37.8 | 1.6% |
|
MDT
Medtronic plc
|
$104.98B | -13.9% | +8.4% | 22.0 | 1.4% |
|
BSX
Boston Scientific Corp
|
$66.60B | -53.0% | +5.5% | 18.8 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ESMC | -5.0% | +0.0% | +18.8% | -5.0% | +11.8% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -4.8% | -0.8% | +11.3% | -4.8% | +2.5% |